Literature DB >> 14043365

ANTIGENIC HISTAMINE RELEASE FROM PASSIVELY SENSITIZED HUMAN LEUDOCYTES.

P P VANARSDEL, C J SELLS.   

Abstract

With histamine release as an indicator, consistent passive sensitization of normal human leukocytes to specific anligen could be achieved with human serum, fresh or stored at -70 degrees C, from allergic individuals. With certain sera, dilution slowed the rate of sensitization but increased eventual histamine release.

Entities:  

Keywords:  ANTIGEN-ANTIBODY REACTIONS; HAY FEVER; HISTAMINE LIBERATION; LEUKOCYTES

Mesh：

Substances：

Year:  1963        PMID： 14043365     DOI： 10.1126/science.141.3586.1190

Source DB:  PubMed          Journal:  Science        ISSN： 0036-8075            Impact factor:   47.728


  6 in total

1.  THE PASSIVE TRANSFER OF IMMEDIATE TYPE HYPERSENSITIVITY FROM MAN TO OTHER PRIMATES.

Authors:  R PATTERSON; J N FINK; E T NISHIMURA; J J PRUZANSKY
Journal:  J Clin Invest       Date:  1965-01       Impact factor: 14.808

2.  IMMUNOLOGIC ASPECTS OF HUMAN REAGINIC ALLERGY: AN IN VITRO METHOD AND SOME APPLICATIONS.

Authors:  A G OSLER; L M LICHTENSTEIN; D A LEVY
Journal:  Naunyn Schmiedebergs Arch Exp Pathol Pharmakol       Date:  1965-02-16

3.  QUANTITATIVE STUDIES ON THE ASSAY OF HUMAN SKIN-SENSITIZING ANTIBODIES (REAGINS). I. AN EXAMINATION OF FACTORS AFFECTING THE ACCURACY OF THE PRAUSNITZ-KUESTNER (P-K) TEST.

Authors:  D R STANWORTH; W J KUHNS
Journal:  Immunology       Date:  1965-04       Impact factor: 7.397

Review 4.  Human reagins: appraisal of the properties of the antibody of immediate-type hypersensitivity.

Authors:  J A Flick
Journal:  Bacteriol Rev       Date:  1972-09

5.  In vitro detection of human reagins by double layer leucocyte agglutination: method and controlled blind study.

Authors:  M E Fitzpatrick; R C Connolly; D J Lea; S A O'Sullivan; R Augustin; M B Macaulay
Journal:  Immunology       Date:  1967-01       Impact factor: 7.397

6.  Histamine release from human leukocytes when stimulated by Mycoplasma salivarium.

Authors:  C F Parkinson
Journal:  Infect Immun       Date:  1975-03       Impact factor: 3.441
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.